The analyst believes Viaskin Peanut provides an "attractive risk/benefit" to peanut allergy
patients and that the implied risk at current share levels is "overly cautious.
Recent milestone trials have demonstrated that early introduction of peanuts can reduce the development of peanut allergy
in at-risk children.
amp;nbsp;"And at the end of treatment and even four years later, many of these children who had benefited from our probiotic peanut therapy could now live like a child who didn't have peanut allergy
THE STUDY: The good news is parents finally have an answer to their question about how to best prevent peanut allergies in the LEAP study (Learning Early About Peanut allergy
M2 EQUITYBITES-August 29, 2017-DBV Technologies enrols 300 patients into Phase III extension trial for peanut allergy
M2 PHARMA-August 29, 2017-DBV Technologies enrols 300 patients into Phase III extension trial for peanut allergy
In the majority of patients, peanut allergy
begins early in life and persists as a lifelong problem," wrote lead author Alkis Togias, MD, of NIAID in Bethesda, Md.
A wearable patch that delivers small amounts of peanut protein through the skin shows promise for treating children and young adults with peanut allergy
, with greater benefits for younger children, according to one-year results from an ongoing clinical trial.
In the study, mice that were bred to have an artificially induced peanut allergy
were fed a high-fiber diet to produce a healthy population of gut bacteria.
Global Markets Direct's, 'Peanut Allergy
- Pipeline Review, H1 2016', provides an overview of the Peanut Allergy
2] Further research into possible strategies to prevent peanut allergy
in high-risk patients has favoured early introduction of peanut protein, which may promote tolerance in selected patients.
Among the 530 infants in the intent-to-treat population who initially had negative results on the skin-prick test, the prevalence of peanut allergy
at 5 years of age was 13.